Robert A Brodner, MD | |
1411 N Flagler Dr, Suite 5900, West Palm Beach, FL 33401-3412 | |
(561) 833-6388 | |
(561) 833-6353 |
Full Name | Robert A Brodner |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 1411 N Flagler Dr, West Palm Beach, Florida |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427035393 | NPI | - | NPPES |
61463 | Other | FL | PROVIDER NUMBER |
04251300 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | ME0046672 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Robert A Brodner, MD 1411 N Flagler Dr, Suite 5900, West Palm Beach, FL 33401-3412 Ph: (561) 833-6388 | Robert A Brodner, MD 1411 N Flagler Dr, Suite 5900, West Palm Beach, FL 33401-3412 Ph: (561) 833-6388 |
News Archive
Just as some people seem built to run marathons and have an easier time going for miles without tiring, others are born with a knack for memorizing things, from times tables to trivia facts. These two skills—running and memorizing—are not so different as it turns out.
The Multiple Myeloma Research Foundation (MMRF) today announced an alliance with US Oncology Research to participate in the landmark CoMMpass (Relating Clinical Outcomes in MM to Personal Assessment of Genetic Profile) study sponsored by the MMRF.
10x Genomics, a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced publication of an article in the journal Nature of a collaborative research study with researchers at the Stanford University School of Medicine.
RedHill Biopharma Ltd. (NASDAQ; RDHL) (TASE: RDHL) ("RedHill" or the "Company"), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer, today announced that it has initiated a randomized, double-blind, 2-arm parallel group Phase II clinical study in the U.S. evaluating the safety and efficacy of BEKINDA™ 12 mg in patients with diarrhea-predominant irritable bowel syndrome (IBS-D).
Discovery of a new drug with high potential to treat Ewing sarcoma, an often deadly cancer of children and young adults, and the previously unknown mechanism behind it, come hand-in-hand in a new study by researchers from Huntsman Cancer Institute (HCI) at the University of Utah. The report appears in today's online issue of the journal Oncogene.
› Verified 8 days ago
Mr. Kaveh Asadi-moghaddam, MD, PHD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 901 45th Street, Kimmel Building, West Palm Beach, FL 33407 Phone: 561-844-5255 Fax: 561-844-5245 | |
Jordan C Grabel, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1411 N Flagler Dr, Suite 5900, West Palm Beach, FL 33401 Phone: 561-833-6388 Fax: 561-833-6353 | |
John K B Afshar, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 901 Village Blvd Ste 702, West Palm Beach, FL 33409 Phone: 561-882-6214 | |
Mr. Yonas Zegeye, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 5 Harvard Cir, Suite 104, West Palm Beach, FL 33409 Phone: 561-603-6652 Fax: 888-563-9455 | |
Dr. Philip Levitt, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 901 45th St, St Marys Medical Center, West Palm Beach, FL 33407 Phone: 561-844-6300 | |
Scott Joseph Raffa, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 901 45th Street, Kimmel Building, West Palm Beach, FL 33407 Phone: 561-844-5255 |